N. Ndemazie, Andriana Inkoom, Xue Y. Zhu, Edward Agyare
{"title":"摘要PO-047:利用MIAPaCa-2和PANC-1细胞优化5-FU作为化疗药物治疗晚期胰腺导管腺癌(PDAC)的疗效","authors":"N. Ndemazie, Andriana Inkoom, Xue Y. Zhu, Edward Agyare","doi":"10.1158/1538-7445.panca21-po-047","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"30 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract PO-047: Optimizing the efficacy of 5-FU as a chemotherapeutic agent in advanced pancreatic ductal adenocarcinoma (PDAC) using MIAPaCa-2 and PANC-1 cells\",\"authors\":\"N. Ndemazie, Andriana Inkoom, Xue Y. Zhu, Edward Agyare\",\"doi\":\"10.1158/1538-7445.panca21-po-047\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":120683,\"journal\":{\"name\":\"Other Topics\",\"volume\":\"30 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Other Topics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.panca21-po-047\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Other Topics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.panca21-po-047","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract PO-047: Optimizing the efficacy of 5-FU as a chemotherapeutic agent in advanced pancreatic ductal adenocarcinoma (PDAC) using MIAPaCa-2 and PANC-1 cells